BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 23278588)

  • 1. Neuromuscular transmission failure in myasthenia gravis: decrement of safety factor and susceptibility of extraocular muscles.
    Serra A; Ruff RL; Leigh RJ
    Ann N Y Acad Sci; 2012 Dec; 1275(1):129-35. PubMed ID: 23278588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors contributing to failure of neuromuscular transmission in myasthenia gravis and the special case of the extraocular muscles.
    Serra A; Ruff R; Kaminski H; Leigh RJ
    Ann N Y Acad Sci; 2011 Sep; 1233():26-33. PubMed ID: 21950972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How myasthenia gravis alters the safety factor for neuromuscular transmission.
    Ruff RL; Lennon VA
    J Neuroimmunol; 2008 Sep; 201-202():13-20. PubMed ID: 18632162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiology of myasthenia gravis.
    Hughes BW; Moro De Casillas ML; Kaminski HJ
    Semin Neurol; 2004 Mar; 24(1):21-30. PubMed ID: 15229789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endplate contributions to the safety factor for neuromuscular transmission.
    Ruff RL
    Muscle Nerve; 2011 Dec; 44(6):854-61. PubMed ID: 22102453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extraocular muscle characteristics related to myasthenia gravis susceptibility.
    Liu R; Xu H; Wang G; Li J; Gou L; Zhang L; Miao J; Li Z
    PLoS One; 2013; 8(2):e55611. PubMed ID: 23409007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of miniature end-plate potential amplitude in extraocular and limb muscles in an animal model of myasthenia gravis.
    Zahm DS; Kim YI; Liu HH; Johns TR
    Exp Neurol; 1983 Apr; 80(1):258-62. PubMed ID: 6832272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre- and post-synaptic abnormalities associated with impaired neuromuscular transmission in a group of patients with 'limb-girdle myasthenia'.
    Slater CR; Fawcett PR; Walls TJ; Lyons PR; Bailey SJ; Beeson D; Young C; Gardner-Medwin D
    Brain; 2006 Aug; 129(Pt 8):2061-76. PubMed ID: 16870884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromuscular synapse electrophysiology in myasthenia gravis animal models.
    Plomp JJ; Huijbers MGM; Verschuuren JJGM
    Ann N Y Acad Sci; 2018 Jan; 1412(1):146-153. PubMed ID: 29068559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homeostatic synaptic plasticity at the neuromuscular junction in myasthenia gravis.
    Wang X; Rich MM
    Ann N Y Acad Sci; 2018 Jan; 1412(1):170-177. PubMed ID: 28981978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utrophin abundance is reduced at neuromuscular junctions of patients with both inherited and acquired acetylcholine receptor deficiencies.
    Slater CR; Young C; Wood SJ; Bewick GS; Anderson LV; Baxter P; Fawcett PR; Roberts M; Jacobson L; Kuks J; Vincent A; Newsom-Davis J
    Brain; 1997 Sep; 120 ( Pt 9)():1513-31. PubMed ID: 9313636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular muscles: physiology and structure-function correlations.
    Ruff R; Kaminski H; Maas E; Spiegel P
    Bull Soc Belge Ophtalmol; 1989; 237():321-52. PubMed ID: 2535014
    [No Abstract]   [Full Text] [Related]  

  • 13. Electrophysiology of postsynaptic activation.
    Ruff RL
    Ann N Y Acad Sci; 1998 May; 841():57-70. PubMed ID: 9668221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evoked responses in normal and diseased muscle with particular reference to twitch potentiation.
    Krarup C
    Acta Neurol Scand; 1983 Nov; 68(5):269-315. PubMed ID: 6320576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myasthenia gravis animal model: quantitative analysis of the efficiency of pre- and postjunctional regions of intercostal muscles in rabbits immunized with Torpedo acetylcholine receptor.
    Albuquerque EX; Eldefrawi AT; Oliveira AC; Copio DS; Eldefrawi ME
    Exp Neurol; 1979 Oct; 66(1):109-22. PubMed ID: 225189
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
    Cole RN; Reddel SW; Gervásio OL; Phillips WD
    Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of agrin on the distribution of acetylcholine receptors and sodium channels on adult skeletal muscle fibers in culture.
    Lupa MT; Caldwell JH
    J Cell Biol; 1991 Nov; 115(3):765-78. PubMed ID: 1655812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disorders affecting the acetylcholine receptor: myasthenia gravis and congenital myasthenia.
    Vincent A
    J Recept Res; 1987; 7(1-4):599-616. PubMed ID: 2442386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Disorders of neuromuscular transmission].
    Kwieciński H
    Neurol Neurochir Pol; 1998; 32 Suppl 1():13-21. PubMed ID: 9608549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuromuscular junction in myasthenia gravis: decreased acetylcholine receptors.
    Fambrough DM; Drachman DB; Satyamurti S
    Science; 1973 Oct; 182(4109):293-5. PubMed ID: 4742736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.